Vos T - Search Results

1

Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020.

Pesudovs K, Lansingh VC, Kempen JH, Tapply I, Fernandes AG, Cicinelli MV, Arrigo A, Leveziel N, Briant PS, Vos T, Resnikoff S, Taylor HR, Sedighi T, Flaxman S, Steinmetz J, Bourne R; Vision Loss Expert Group of the Global Burden of Disease Study; GBD 2019 Blindness and Vision Impairment Collaborators. Pesudovs K, et al. Among authors: vos t. Eye (Lond). 2024 Mar 9. doi: 10.1038/s41433-024-02961-1. Online ahead of print. Eye (Lond). 2024. PMID: 38461217

2

Cost-effectiveness of prescribing statins according to pharmaceutical benefits scheme criteria.

Lim SS, Vos T, Peeters A, Liew D, McNeil JJ. Lim SS, et al. Among authors: vos t. Med J Aust. 2001 Nov 5;175(9):459-64. doi: 10.5694/j.1326-5377.2001.tb143676.x. Med J Aust. 2001. PMID: 11758073

3

Epidemiological modelling (including economic modelling) and its role in preventive drug therapy.

Liew D, McNeil JJ, Peeters A, Lim SS, Vos T. Liew D, et al. Among authors: vos t. Med J Aust. 2002 Oct 7;177(7):364-7. doi: 10.5694/j.1326-5377.2002.tb04839.x. Med J Aust. 2002. PMID: 12358579

4

Reductions in child mortality levels and inequalities in Thailand: analysis of two censuses.

Vapattanawong P, Hogan MC, Hanvoravongchai P, Gakidou E, Vos T, Lopez AD, Lim SS. Vapattanawong P, et al. Among authors: vos t. Lancet. 2007 Mar 10;369(9564):850-855. doi: 10.1016/S0140-6736(07)60413-9. Lancet. 2007. PMID: 17350454

5

Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study.

Gartner CE, Hall WD, Vos T, Bertram MY, Wallace AL, Lim SS. Gartner CE, et al. Among authors: vos t. Lancet. 2007 Jun 16;369(9578):2010-2014. doi: 10.1016/S0140-6736(07)60677-1. Lancet. 2007. PMID: 17498798 Free article.

6

Global burden of disease 2005: call for collaborators.

Murray CJ, Lopez AD, Black R, Mathers CD, Shibuya K, Ezzati M, Salomon JA, Michaud CM, Walker N, Vos T. Murray CJ, et al. Among authors: vos t. Lancet. 2007 Jul 14;370(9582):109-110. doi: 10.1016/S0140-6736(07)61064-2. Lancet. 2007. PMID: 17630021 No abstract available.

7

Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia.

Bertram MY, Lim SS, Wallace AL, Vos T. Bertram MY, et al. Among authors: vos t. Tob Control. 2007 Aug;16(4):255-60. doi: 10.1136/tc.2006.017657. Tob Control. 2007. PMID: 17652241 Free PMC article.

8

Assessing the cost-effectiveness of drug and lifestyle intervention following opportunistic screening for pre-diabetes in primary care.

Bertram MY, Lim SS, Barendregt JJ, Vos T. Bertram MY, et al. Among authors: vos t. Diabetologia. 2010 May;53(5):875-81. doi: 10.1007/s00125-010-1661-8. Epub 2010 Feb 5. Diabetologia. 2010. PMID: 20135088 Free article.

9

Contribution of vision loss to the Indigenous health gap.

Vos T, Taylor HR. Vos T, et al. Clin Exp Ophthalmol. 2013 Apr;41(3):309-10. doi: 10.1111/j.1442-9071.2012.02852.x. Epub 2012 Sep 17. Clin Exp Ophthalmol. 2013. PMID: 22788852 No abstract available.

10

GBD 2010: a multi-investigator collaboration for global comparative descriptive epidemiology.

Murray CJ, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C, Naghavi M, Salomon JA, Shibuya K, Vos T, Lopez AD. Murray CJ, et al. Among authors: vos t. Lancet. 2012 Dec 15;380(9859):2055-8. doi: 10.1016/S0140-6736(12)62134-5. Lancet. 2012. PMID: 23245598 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

577 results

Search Page